Figures & data
![](/cms/asset/1363bf78-7258-4e7a-b45f-1ccef394c777/dijn_a_12192538_uf0001_c.jpg)
Figure 1 Schematic representation of the mechanism of B. hispica fruit proteins mediated synthesis of biogenic AgNPs and their roles in anticancer, antibacterial, and antibiofilm agents.
![Figure 1 Schematic representation of the mechanism of B. hispica fruit proteins mediated synthesis of biogenic AgNPs and their roles in anticancer, antibacterial, and antibiofilm agents.](/cms/asset/cdef335c-0926-443f-8367-90f816bb8ece/dijn_a_12192538_f0001_c.jpg)
Figure 2 Characterization of B. hispida fruit proteins mediated synthesis of AgNPs by physical techniques: (A) UV-visible spectrum, (B) TEM Micrograph with light gray protein Corona mark by an arrow, (C) size distribution by DLS (D) zeta potential (E) surface characterization by FTIR spectrum.
![Figure 2 Characterization of B. hispida fruit proteins mediated synthesis of AgNPs by physical techniques: (A) UV-visible spectrum, (B) TEM Micrograph with light gray protein Corona mark by an arrow, (C) size distribution by DLS (D) zeta potential (E) surface characterization by FTIR spectrum.](/cms/asset/2194f579-ca16-4aae-b825-60b6e14585f4/dijn_a_12192538_f0002_c.jpg)
Figure 3 Graph showing the antibacterial potential of silver nanoparticles. All the data were expressed in mean ±SD of three experiments.
![Figure 3 Graph showing the antibacterial potential of silver nanoparticles. All the data were expressed in mean ±SD of three experiments.](/cms/asset/0a9b9726-8b6a-4ccc-b09c-2a4d0939e29e/dijn_a_12192538_f0003_c.jpg)
Figure 4 Image and graph showing inhibition of biofilm formation of silver nanoparticles. All the data were expressed in the mean ±SD of three experiments.
![Figure 4 Image and graph showing inhibition of biofilm formation of silver nanoparticles. All the data were expressed in the mean ±SD of three experiments.](/cms/asset/e7bb90fb-198c-4baa-8a92-62c9de0721fe/dijn_a_12192538_f0004_c.jpg)
Figure 5 The cytotoxicity study graph of MTT assay for AgNPs treatment against (A) A549 cells and (B) NRK cells.
![Figure 5 The cytotoxicity study graph of MTT assay for AgNPs treatment against (A) A549 cells and (B) NRK cells.](/cms/asset/c86a678e-6c1d-4ad6-b557-7f8719cd5d67/dijn_a_12192538_f0005_b.jpg)
Figure 6 The cytomorphological study of AgNPs treated A549 cells (A) control, (B) IC25 (C) IC50, (D) IC75 at 20× magnification.
![Figure 6 The cytomorphological study of AgNPs treated A549 cells (A) control, (B) IC25 (C) IC50, (D) IC75 at 20× magnification.](/cms/asset/b0e02c81-68be-4322-92cc-4ef274b79427/dijn_a_12192538_f0006_b.jpg)